The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: A sub-analysis of the Japan hypertension evaluation with angiotensin II antagonist losartan therapy (J-HEALTH) study, a prospective nationwide observational study

Hypertension Research

Volumn 31, Issue 10, 2008, Pages 1903-1911

  Shimada, Kazuyuki ^a   Fujita, Toshiro ^b   Ito, Sadayoshi ^c   Naritomi, Hiroaki ^d   Ogihara, Toshio ^e   Shimamoto, Kazuaki ^f   Tanaka, Heizo ^g   Yoshiike, Nobuo ^h  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KOSHIEN UNIVERSITY   (Japan)

^h NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LOSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE CONTROL; DRUG DOSE INCREASE; FEMALE; HEART INFARCTION; HOME MONITORING; HUMAN; HYPERTENSION; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MORNING DOSAGE; OBSERVATIONAL STUDY; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; WHITE COAT HYPERTENSION; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFECT; FOLLOW UP; JAPAN; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS; STROKE;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; LOSARTAN; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 58149385677     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1903     Document Type: Article

References (33)

1. Amery A, Birkenhager W, Brixko P, et al: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-1354.
2. Bulpitt CJ, Palmer AJ, Fletcher AE, et al: Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994; 90: 225-233.
3. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
4. Clement DL, De Buyzere ML, De Bacquer DA, et al: Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415.
5. Dolan E, Stanton A, Thijs L, et al: Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 2005; 46: 156-161.
6. Staessen JA, Thijs L, Fagard R, et al: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539-546.
7. Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
8. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH: How common is white coat hypertension? JAMA 1988; 259: 225-228.
9. Celis H, Den Hond E, Staessen JA: Self-measurement of blood pressure at home in the management of hypertension. Clin Med Res 2005; 3 19-26.
10. Pickering TG, Davidson K, Gerin W, Schwarts JE: Masked hypertension. Hypertension 2002; 40: 795-796.
11. Naritomi H, Fujita T, Ito S, et al: Efficacy and safety of long-term losartan therapy demonstrated by a cohort study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study. Hypertens Res 2008; 31: 295-304.
12. Thijs L, Staessen JA, Celis H, et al: Reference values for self-recorded blood pressure: A meta-analysis of summary data. Arch Intern Med 1998; 158: 481-488.
13. Staessen JA, Den Hond E, Celis H, et al: Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: A randomized controlled trial. JAMA 2004; 291: 955-964.
14. Staessen JA, Wang J, Bianchi G, Birkenhager WH: Essential hypertension. Lancet 2003; 361: 1629-1641.
15. Den Hond E, Celis H, Fagard R, et al: Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens 2003; 21: 717-722.
16. Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
17. Shimamoto K, Fujita T, Ito S, et al: Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a prospective nationwide observational study. Hypertens Res 2008; 31: 469-478.
18. Naritomi H, Fujita T, Ito S, et al: Design and baseline characteristics of a cohort study in Japanese patients with hypertension: Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH). Hypertens Res 2007; 30 807-814.
19. O'Brien E, Asmar R, Beilin L, et al: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-848.
20. Tsuji I, Imai Y, Nagai K, et al: Proposal of reference values for home blood pressure measurement: Prognostic criteria based on a prospective observation of the general population in Ohasama, Japan. Am J Hypertens 1997; 10: 409-418.
21. Bobrie G, Genes N, Vaur L, et al: Is "isolated home" hypertension as opposed to "isolated office" hypertension a sign of greater cardiovascular risk? Arch Intern Med 2001; 161: 2205-2211.
22. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
23. Khattar RS, Senior R, Lahiri A: Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study. Circulation 1998; 98: 1892-1897.
24. Martinez MA, Garcia-Puig J, Martin JC, et al: Frequency and determinants of white coat hypertension in mild to moderate hypertension: A primary care-based study. Am J Hypertens 1999; 12: 251-259.
25. Bobrie G, Chatellier G, Genes N, et al: Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349.
26. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R: Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47: 846-853.
27. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB: Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26: 413-419.
28. Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL: Whitecoat hypertension as a cause of cardiovascular dysfunction. Lancet 1996; 348: 654-657.
29. Karter Y, Curgunlu A, Altinisik S, et al: Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Press 2003; 12: 307-313.
30. Palatini P, Mormino P, Santonastaso M, et al: Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: Results from the HARVEST study. Hypertension 1998; 31: 57-63.
31. Pierdomenico SD, Lapenna D, Guglielmi MD, et al: Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26: 801-807.
32. Segre CA, Ueno RK, Warde KR, et al: White-coat hypertension and normotension in the league of hypertension of the hospital das clinicas, FMUSP: Prevalence, clinical and demographic characteristics. Arq Bras Cardiol 2003; 80: 117-126.
33. Ohkubo T, Kikuya M, Metoki H, et al: Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring: 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46: 508-515.